Procter & Gamble Health Ltd announced an interim dividend of ₹160 per equity share for FY26, including a one-time special dividend of ₹50 per share. The company said the dividend will be paid on or before March 4, 2026, with February 12, 2026 fixed as the record date.
For the December quarter, the company posted a mixed operational performance. Net profit declined 14.7% year-on-year to ₹77.6 crore, compared with ₹91 crore in the corresponding period last year. EBITDA fell 10.5% to ₹110.6 crore from
₹123.6 crore, while operating margins contracted sharply to 29.6% from 39.9% a year ago, reflecting cost pressures despite higher sales.
Revenue grew a healthy 20.7% year-on-year to ₹374 crore, up from ₹309.8 crore, indicating strong top-line momentum during the quarter even as profitability moderated.
Following the earnings announcement, shares of Procter & Gamble Health Ltd were trading 1.03% lower at ₹5,190 on the NSE.
Also Read: Kaynes Tech Q3 Results: Shares fall 6% after earnings miss across the board, guidance cut
Procter & Gamble Health is engaged in the manufacture and marketing of consumer healthcare products in India, with a focus on vitamins, minerals and wellness solutions.


/images/ppid_59c68470-image-177081525337143071.webp)

/images/ppid_59c68470-image-177081754567635886.webp)

/images/ppid_59c68470-image-177081757873750390.webp)
/images/ppid_59c68470-image-177081756864630974.webp)
/images/ppid_59c68470-image-1770817534750327.webp)


/images/ppid_59c68470-image-177081753982939074.webp)